Standard

Prospects for the Development of Anti-Influenza Drugs Based on Medicinal Mushrooms (Review). / Teplyakova, T. V.; Ilyicheva, T. N.; Markovich, N. A.

In: Applied Biochemistry and Microbiology, Vol. 56, No. 5, 01.09.2020, p. 489-496.

Research output: Contribution to journal › Article › peer-review

Harvard

Teplyakova, TV, Ilyicheva, TN & Markovich, NA 2020, 'Prospects for the Development of Anti-Influenza Drugs Based on Medicinal Mushrooms (Review)', Applied Biochemistry and Microbiology, vol. 56, no. 5, pp. 489-496. https://doi.org/10.1134/S0003683820050142

APA

Teplyakova, T. V., Ilyicheva, T. N., & Markovich, N. A. (2020). Prospects for the Development of Anti-Influenza Drugs Based on Medicinal Mushrooms (Review). Applied Biochemistry and Microbiology, 56(5), 489-496. https://doi.org/10.1134/S0003683820050142

Vancouver

Teplyakova TV, Ilyicheva TN, Markovich NA. Prospects for the Development of Anti-Influenza Drugs Based on Medicinal Mushrooms (Review). Applied Biochemistry and Microbiology. 2020 Sept 1;56(5):489-496. doi: 10.1134/S0003683820050142

Author

Teplyakova, T. V. ; Ilyicheva, T. N. ; Markovich, N. A. / Prospects for the Development of Anti-Influenza Drugs Based on Medicinal Mushrooms (Review). In: Applied Biochemistry and Microbiology. 2020 ; Vol. 56, No. 5. pp. 489-496.

BibTeX

@article{c328e3171fb043cdbb023a8b0277a4df,
title = "Prospects for the Development of Anti-Influenza Drugs Based on Medicinal Mushrooms (Review)",
abstract = "Russian and international publications on the antiviral activity of medicinal mushrooms against influenza, which have been studied in cell culture and animal models, on the presence of sialidase (neuraminidase) inhibitors and RNA polymerase inhibitors of influenza virus are considered. The activity against influenza of both aqueous extracts of higher fungi and the polysaccharides, peptidoglycans, proteins, melanin, polyphenols, and terpenoids present in them is described. It is noted that further studies of the antiviral mechanisms of these components of medicinal mushrooms, both those grown in natural conditions and those cultivated with solid-phase or submerged methods in laboratory and factory conditions, are required in order to develop drugs based on them.",
keywords = "Basidiomycota, cultivation, influenza virus, inhibition, medicinal mushrooms, melanin, neuraminidase, polyphenols, polysaccharides, RNA polymerase, sialidase, terpenoids, IMMUNE-RESPONSE, FRUITING BODY, INFLUENZA, PHYSICOCHEMICAL PROPERTIES, SUPPLEMENTATION, CORRELATED COMPOUND IMPROVES, IN-VITRO, NEURAMINIDASE INHIBITORS, ANTIVIRAL ACTIVITY, POLYSACCHARIDE",
author = "Teplyakova, {T. V.} and Ilyicheva, {T. N.} and Markovich, {N. A.}",
year = "2020",
month = sep,
day = "1",
doi = "10.1134/S0003683820050142",
language = "English",
volume = "56",
pages = "489--496",
journal = "Applied Biochemistry and Microbiology",
issn = "0003-6838",
publisher = "Maik Nauka-Interperiodica Publishing",
number = "5",

}

RIS

TY - JOUR

T1 - Prospects for the Development of Anti-Influenza Drugs Based on Medicinal Mushrooms (Review)

AU - Teplyakova, T. V.

AU - Ilyicheva, T. N.

AU - Markovich, N. A.

PY - 2020/9/1

Y1 - 2020/9/1

N2 - Russian and international publications on the antiviral activity of medicinal mushrooms against influenza, which have been studied in cell culture and animal models, on the presence of sialidase (neuraminidase) inhibitors and RNA polymerase inhibitors of influenza virus are considered. The activity against influenza of both aqueous extracts of higher fungi and the polysaccharides, peptidoglycans, proteins, melanin, polyphenols, and terpenoids present in them is described. It is noted that further studies of the antiviral mechanisms of these components of medicinal mushrooms, both those grown in natural conditions and those cultivated with solid-phase or submerged methods in laboratory and factory conditions, are required in order to develop drugs based on them.

AB - Russian and international publications on the antiviral activity of medicinal mushrooms against influenza, which have been studied in cell culture and animal models, on the presence of sialidase (neuraminidase) inhibitors and RNA polymerase inhibitors of influenza virus are considered. The activity against influenza of both aqueous extracts of higher fungi and the polysaccharides, peptidoglycans, proteins, melanin, polyphenols, and terpenoids present in them is described. It is noted that further studies of the antiviral mechanisms of these components of medicinal mushrooms, both those grown in natural conditions and those cultivated with solid-phase or submerged methods in laboratory and factory conditions, are required in order to develop drugs based on them.

KW - Basidiomycota

KW - cultivation

KW - influenza virus

KW - inhibition

KW - medicinal mushrooms

KW - melanin

KW - neuraminidase

KW - polyphenols

KW - polysaccharides

KW - RNA polymerase

KW - sialidase

KW - terpenoids

KW - IMMUNE-RESPONSE

KW - FRUITING BODY

KW - INFLUENZA

KW - PHYSICOCHEMICAL PROPERTIES

KW - SUPPLEMENTATION

KW - CORRELATED COMPOUND IMPROVES

KW - IN-VITRO

KW - NEURAMINIDASE INHIBITORS

KW - ANTIVIRAL ACTIVITY

KW - POLYSACCHARIDE

UR - http://www.scopus.com/inward/record.url?scp=85091320726&partnerID=8YFLogxK

U2 - 10.1134/S0003683820050142

DO - 10.1134/S0003683820050142

M3 - Article

AN - SCOPUS:85091320726

VL - 56

SP - 489

EP - 496

JO - Applied Biochemistry and Microbiology

JF - Applied Biochemistry and Microbiology

SN - 0003-6838

IS - 5

ER -

ID: 25645119